Close Menu

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

The alliance builds on an earlier agreement between Gilbertsville, Pa.-based Rpckland and LIMR, which is a business development subsidiary of the Lankenau Institute for Medical Research.

Under the new agreement, Rockland will sell LIMR's CellCountEZ, OxPhos, RadDose, and Intracellular ThiolEZ assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.